Company Filing History:
2 out of 78 
2 out of 15,475 
1 out of 832,843 Years Active: 1994-2002
Title: Arthur Weiss: Innovator in Chimeric Protein Technology
Introduction
Arthur Weiss is a prominent inventor based in Mill Valley, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric proteins. With a total of 4 patents to his name, Weiss has been at the forefront of innovations that enhance our understanding of receptor-associated signal transduction pathways.
Latest Patents
Weiss's latest patents focus on chimeric chains for receptor-associated signal transduction pathways. These patents describe chimeric proteins and the DNA encoding them, characterized by an extracellular domain capable of binding to a ligand in a non-MHC restricted manner. The proteins also include a transmembrane domain and a cytoplasmic domain that can activate a signaling pathway. The unique combination of these domains, which are not naturally found together, allows for the transduction of signals upon ligand binding. This activation can induce various cellular functions related to the signaling pathway. The chimeric DNA has potential applications in modifying lymphocytes and hematopoietic stem cells, serving as precursors to important cell types.
Career Highlights
Throughout his career, Arthur Weiss has worked with notable organizations, including Cell Genesys, Inc. and the University of California. His work has significantly impacted the field of immunology and biotechnology, paving the way for advancements in therapeutic applications.
Collaborations
Weiss has collaborated with esteemed colleagues such as Daniel J Capon and Brian A Irving. These partnerships have further enriched his research and contributed to the development of innovative technologies in his field.
Conclusion
Arthur Weiss stands out as a key figure in the realm of chimeric protein technology. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving therapeutic strategies. His work continues to inspire future innovations in biotechnology.